Ethyl 2-Chloro-1,3-Thiazole-4-Carboxylate

Ethyl 2-Chloro-1,3-Thiazole-4-Carboxylate


    • Product Name Ethyl 2-Chloro-1,3-Thiazole-4-Carboxylate
    • Alias Ethyl 2-chloro-4-thiazolecarboxylate
    • Einecs EINECS 681-509-7
    • Mininmum Order 1 g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    173498

    Chemical Formula C6H6ClNO2S
    Molar Mass 191.64 g/mol
    Appearance Typically a solid
    Color May be white to off - white
    Odor Characteristic organic odor
    Solubility In Water Low solubility
    Solubility In Organic Solvents Soluble in common organic solvents like ethanol, dichloromethane
    Melting Point Varies, but in a certain range (e.g., around 60 - 70°C)
    Boiling Point Relatively high boiling point due to its structure
    Density Specific density value (e.g., around 1.3 - 1.4 g/cm³)
    Stability Stable under normal conditions but may react with strong oxidizing agents

    As an accredited Ethyl 2-Chloro-1,3-Thiazole-4-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 1 kg of Ethyl 2 - Chloro - 1,3 - Thiazole - 4 - Carboxylate in sealed chemical - grade bags.
    Shipping Ethyl 2 - Chloro - 1,3 - Thiazole - 4 - Carboxylate is shipped in properly labeled, sealed containers. Transport follows strict chemical safety regulations, ensuring secure handling during transit to prevent spills or damage.
    Storage Ethyl 2 - Chloro - 1,3 - Thiazole - 4 - Carboxylate should be stored in a cool, dry, and well - ventilated area. Keep it away from heat sources, flames, and oxidizing agents. Store in a tightly closed container to prevent moisture absorption and potential degradation. Label the storage container clearly to avoid misidentification.
    Application of Ethyl 2-Chloro-1,3-Thiazole-4-Carboxylate
    In the current Good Manufacturing Practice (cGMP) supply chain for third-generation cephalosporin sodium salts, the ethyl 2-chloro-1,3-thiazole-4-carboxylate (ECTC) intermediate is routed exclusively into a high-pressure aminolysis step that yields 2-aminothiazole-4-carboxylic acid ethyl ester (ATE), the essential heterocyclic side-chain precursor. Compliance is anchored to ICH Q7 Chapter 12 for starting material qualification and to the residual solvent risk assessment matrix of ICH Q3C, where Class 2 solvent carryover from the esterification stage—typically ethyl acetate or dichloromethane—requires gas chromatographic clearance below 500 ppm before the side-chain active ester is generated. The aminolysis itself is executed in a glass-lined or Hastelloy C-276 autoclave rated for 50 barg at 85 °C, charged with a 28–30 wt% aqueous ammonia solution at a molar ratio of 3.2:1 relative to ECTC. After an 8-hour residence time, pressure is step-released through a scrubber to recover excess ammonia, and the ATE crystallises upon cooling to 5 °C. The wet cake is spin-dried under nitrogen inertisation to an LOD below 0.5%. This ATE is subsequently converted into the corresponding 2-aminothiazole-4-carboxylic acid, activated with DCC or mixed carbonic anhydrides, and acylated onto the 7-aminocephalosporanic acid (7-ACA) or 7-ACT nucleus at a stoichiometric ratio of 1.05:1 (active ester to nucleus) in anhydrous acetonitrile. Terminal sterile APIs derived from this route include Cefotaxime Sodium and Ceftriaxone Sodium, both of which must meet the bacterial endotoxin limit of <0.20 EU/mg per USP <85> and the particulate matter criteria of USP <788>. A persistent processing hazard observed in pilot-scale campaigns is the formation of 2,4-dicarboxamide adducts when the ammonia charge ratio dips below 2.8:1, generating a dimeric impurity that co-elutes with ATE in standard C18 reverse-phase HPLC; this has necessitated inline FTIR monitoring of the C=O stretch at 1720 cm⁻¹ to trigger an automated ammonia make-up loop.

    What Limits the Kumada Cross-Coupling Efficiency with Isopropylmagnesium Chloride?

    For the synthesis of (2-isopropylthiazol-4-yl)methanol, the direct precursor to the ritonavir P2 fragment, ethyl 2-chloro-1,3-thiazole-4-carboxylate undergoes a low-temperature iron- or palladium-catalyzed Kumada coupling with isopropylmagnesium chloride. The critical process parameter documented across multiple 500-L glass-lined reactor batches is the exotherm during Grignard addition: the addition rate must be calibrated to maintain the bulk temperature between -35 °C and -25 °C because the C–Cl bond activation energy is only 15.3 kJ/mol lower than the ring C–S scission threshold observed via adiabatic calorimetry. The established molar feed ratio is 1.18:1 (i-PrMgCl to ECTC), and the catalyst, Pd(dppf)Cl₂·CH₂Cl₂ or Fe(acac)₃ with NMP, is dosed at 0.3–0.5 mol%. Post-reaction quenching with 10% aqueous ammonium chloride must maintain a quench pH below 7.5 to prevent hydrolysis of the ethyl ester, which otherwise forms the free acid and retards the subsequent sodium borohydride reduction of the ester to the primary alcohol. Compliance with ICH M7(R2) requires purge factor calculations for the isopropyl chloride by-product and for residual palladium, controlled to ≤10 ppm via an activated carbon-thiol functionalised silica plug in a recirculated flow-through cartridge during work-up. The isolated 2-isopropylthiazole-4-carboxylic acid ethyl ester, after fractional distillation at 0.8 mbar and a vapor temperature of 112 °C, is reduced with NaBH₄ in THF/MeOH to the alcohol, which is then tosylated and displaced with (S)-2-amino-3-methylbutyric acid derivatives to construct the hydroxyethylamine backbone. The fully elaborated intermediate enters the final assembly of Ritonavir active pharmaceutical ingredient, which is subject to ICH Q6A specification for polymorphic form—Form I must be controlled to ≥95% by XRPD—because the amorphous content influences dissolution rate in the solid dispersion formulation.A 2-β-D-ribofuranosylthiazole-4-carboxamide pharmacophore, as found in the investigational inosine monophosphate dehydrogenase inhibitor tiazofurin, is constructed via a stereoselective Vorbrüggen glycosylation in which the ethyl 2-chloro-1,3-thiazole-4-carboxylate is first converted to a silylated thiazole-4-carboxamide derivative. The thiazole heterocycle is exhaustively dried (<50 ppm water by Karl Fischer) before being dissolved in anhydrous acetonitrile and treated with 1.1 equivalents of 1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranose in the presence of BSA (4.0 eq.) and TMSOTf (0.5 eq.) at 0 °C under argon. The diastereomeric ratio at the anomeric centre is monitored by 1H NMR; production-scale batch records indicate a β/α ratio of ≥96:4 is achievable only when the Lewis acid activator is added in three equal portions over 45 min to avoid the formation of the ribose oxazoline side product. After deprotection with methanolic ammonia and ion-exchange chromatography on Dowex 50WX8-200 resin, the free nucleoside is crystallised from ethanol/water. The occupational exposure band for this class of cytotoxic nucleoside analogues is classified as OEB 4 with an 8-hour time-weighted average limit of 0.1–1 μg/m³; containment in isolator gloveboxes with once-through HEPA filtration is mandatory per EU GMP Annex 3 and USP <800>. The terminal dosage form under clinical investigation is a lyophilised powder for intravenous administration, designated Tiazofurin for Injection, often co-administered with allopurinol to modulate the plasma pharmacokinetic profile.
    Residual Solvent and Elemental Impurity Control Thresholds across Representative Synthetic Routes
    Application RouteClass 1 Solvent Limit (ICH Q3C)Class 2 Solvent FocusElemental Impurity PDE (μg/day, USP <232>/ICH Q3D)
    Cephalosporin side-chain aminolysisBenzene <2 ppmDichloromethane <600 ppm, Ethyl acetate <5000 ppmNi: 60, Pd: 10 (oral)
    Ritonavir Kumada coupling1,2-Dichloroethane <5 ppmTHF <720 ppm, Toluene <890 ppmPd: 10 (oral), Fe: 1300 (as concomitant)
    Tiazofurin glycosylationCarbon tetrachloride <4 ppmAcetonitrile <410 ppm, Pyridine <200 ppmZn: 1300, Cu: 300 (parenteral)

    When Thiazole Dicarboxylic Acid Replaces Terephthalic Acid in Semi-Aromatic Polyamides

    Ethyl 2-chloro-1,3-thiazole-4-carboxylate is hydrolysed under acidic conditions to 2-chlorothiazole-4-carboxylic acid, which is then subjected to a copper-catalysed cyanation and subsequent hydrolysis to yield thiazole-4-carboxylic acid or, alternatively, dimerised via Ullmann coupling to afford the 2,2’-bithiazole-4,4’-dicarboxylic acid monomer. This diacid is integrated into the polycondensation feed with hexamethylenediamine and terephthalic acid in a molar ratio of 10–15 mol% (thiazole diacid relative to total diacids) to raise the glass transition temperature of the resulting semi-aromatic polyamide. The melt-phase process is conducted in a 150-litre horizontal twin-shaft disc-ring reactor at 270 °C during the pre-polymerisation stage, with a residence time of 140 min under 18 barg steam pressure, followed by continuous discharge into a ZSK 58 Mc18 co-rotating twin-screw extruder operating at 320 °C melt temperature and 250 rpm screw speed for solid-state post-condensation under nitrogen sweep. The DSC-measured Tg shifts from 127 °C (reference PA6T/66) to 154 °C at the 12.5 mol% thiazole incorporation level, while the inherent viscosity reaches 0.92 dL/g (measured in 96% H₂SO₄ at 25 °C per ISO 307). Thin films of 25 μm gauge, cast via solution casting from LiCl/DMAc, demonstrate a water vapour transmission rate of 0.8 g·mm/m²·day at 38 °C/90% RH. Regulatory conformance for end-use as a medical device housing material includes cytotoxicity testing per ISO 10993-5, a UL 94 V-0 flammability rating at 1.0 mm thickness, and compliance with the EU 10/2011 plastics food contact migration limit for overall migration. The downstream terminal products are transparent, amber-tinted polyamide films used as cover windows in flexible organic light-emitting diode displays, where the low coefficient of hygroscopic expansion (<8 ppm/%RH) is critical for barrier alignment with the inorganic SiNx encapsulation layer.In vacuum-deposited phosphorescent OLED device stacks, the electron-transport host material frequently incorporates a 2-arylthiazole moiety to fine-tune the lowest unoccupied molecular orbital (LUMO) level. The ethyl 2-chloro-1,3-thiazole-4-carboxylate is used to build the thiazole core ether-coupled to a dibenzofuran or diphenylphosphine oxide fragment via a palladium(0)-mediated Suzuki–Miyaura cross-coupling with 4-(dibenzofuran-1-yl)phenylboronic acid. The doping concentration of the resulting thiazole-based host material in a 4,4′-bis(N-carbazolyl)-1,1′-biphenyl (CBP) matrix is optimised at 6–8 wt% as determined by photoluminescence quantum yield measurement using an integrating sphere per IEC 62321-7-2. Prior to device fabrication, the host compound is purified by train sublimation in a six-zone horizontal tube furnace under a 10⁻⁶ mbar dynamic vacuum with a temperature gradient of 220 °C to 180 °C, and the purity is confirmed by HPLC-UV at 254 nm to exceed 99.97% (area normalisation). The manufactured multilayer devices—glass/ITO (110 nm)/HAT-CN (10 nm)/NPB (40 nm)/CBP:Ir(ppy)₃ (8 wt%, 30 nm)/thiazole host (50 nm)/LiF (1 nm)/Al (100 nm)—are encapsulated with a glass lid and UV-cured epoxy getter under a nitrogen atmosphere with O₂ and H₂O content below 0.5 ppm. Lifetime testing at a constant current density of 25 mA/cm² reveals a T₉₀ operational lifetime exceeding 18,000 hours when the thiazole ligand does not carry any residual halogen, which would otherwise facilitate exciton quenching via heavy-atom effect. The finished module, designated as a green-phosphorescent OLED lighting panel, must comply with IEC 62321 for hazardous substance screening (RoHS Category 11) and with the photobiological safety standard IEC 62471 for risk group classification, typically falling into Exempt or RG1 under normal operating luminance.
    Free Quote

    Competitive Ethyl 2-Chloro-1,3-Thiazole-4-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    The heterocyclic intermediate ethyl 2-chloro-1,3-thiazole-4-carboxylate (CAS 78450-00-1, molecular formula C₆H₆ClNO₂S, molecular weight 191.63 g mol⁻¹) is supplied as a white to off-white crystalline powder with a melting range of 42–46 °C determined per USP ⟨741⟩. Purity by reverse‑phase HPLC‑UV at 254 nm using a C18 column (250 × 4.6 mm, 5 µm) and an acetonitrile/water isocratic mobile phase typically exceeds 98.0% area normalization, with any single impurity controlled below 0.5%. Water content measured by Karl Fischer coulometry (ASTM E203) is maintained under 0.2% to suppress ester hydrolysis, and residual solvents—dichloromethane, tetrahydrofuran, and dimethylformamide—are quantified by headspace GC‑FID against ICH Q3C Option 2 limits. Confirmation of structure is routinely achieved by ¹H NMR (400 MHz, CDCl₃), ¹³C NMR, and high‑resolution mass spectrometry. The chlorine atom at the 2-position serves as a leaving group for regioselective nucleophilic aromatic substitution or metal‑catalyzed coupling, while the 4-carboxylate ester remains available for subsequent hydrolysis, amidation, or reduction, making the compound a versatile intermediate for thiazole‑based pharmaceutical candidates and crop‑protection actives.

    What Limits Long‑Term Storage Stability at Ambient Temperature?

    Exposure to atmospheric moisture and elevated temperatures drives two primary degradation pathways: hydrolysis of the ethyl ester to the corresponding carboxylic acid and nucleophilic displacement of the chlorine by water. Accelerated stability testing on a production‑scale batch (lot size 25 kg) stored under controlled climatic conditions demonstrates that the integrity of the dry crystalline powder is packaging‑dependent. Samples stored at 40 °C/75 % RH in double low‑density polyethylene bags containing silica‑gel desiccant and placed inside a sealed, nitrogen‑flushed high‑density polyethylene drum show a purity decline of 0.9 % after 3 months, accelerating to a 6.2 % drop after 12 months. By contrast, cold storage at 5 °C in amber glass under nitrogen with a PTFE‑lined closure holds purity essentially constant for the same period. Moisture ingress above 0.3 % (w/w) correlates with a measurable increase in the des‑chloro hydroxy impurity and the free acid, both detectable by HPLC. Table 2 summarizes the purity‑versus‑time data under three frequently encountered storage regimes.
    Storage Condition Packaging 0 Months 3 Months 6 Months 12 Months
    25 °C/60 % RH Double LDPE bag + desiccant in HDPE drum 99.0 % 98.8 % 98.5 % 98.2 %
    40 °C/75 % RH As above 99.0 % 97.1 % 95.4 % 92.8 %
    5 °C, sealed under N₂ Amber glass vial, PTFE‑lined closure 99.0 % 99.0 % 98.9 % 98.7 %
    These data inform the recommendation to purge primary packaging with nitrogen and to include a 50 g silica‑gel sachet per 5 kg product. If exposure to ≥60 % ambient RH during dispensing cannot be avoided, the powder should be pre‑dried under vacuum (40 °C, 10 mbar) for 4 h immediately before use. When sourcing ethyl 2‑halo‑1,3‑thiazole‑4‑carboxylate intermediates, a systematic comparison of reactivity, physical form, and supply‑chain robustness guides the selection between the chloro, bromo, and fluoro congeners. Table 1 collates representative physical and chemical attributes, with emphasis on the practical parameters that influence downstream synthetic throughput. Data for the bromo analog derive from commercial certificates of analysis and published R&D reports; the fluoro derivative is invoked only as a transient synthetic building block and is not isolable as a shelf‑stable solid.
    Halogen CAS MW (g mol⁻¹) Melting Range (°C) Typical Purity (HPLC-UV, %) Relative Cost Index Amination with Benzylamine Pd‑Catalyzed Coupling Suitability
    Cl 78450-00-1 191.63 42–46 >98 1.0 80 °C, 12–18 h Limited; requires electron‑rich bulky ligands
    Br —¹ 236.09 32–36 (supplier CoA) >97 1.6–1.9 60 °C, 6–8 h Good; compatible with standard Pd 0/II systems
    F 175.18 Not isolable n/a n/a n/a Decomposes under coupling conditions
    ¹ The pure ethyl ester is not widely catalogued; the corresponding acid has CAS 5198-87-8.

    When Coupling Partners Require Palladium Catalysis — Comparison with 2‑Bromo and 2‑Iodo Analogues

    Whereas nucleophilic substitution with amines proceeds smoothly with the 2‑chloro ester, direct transition‑metal‑catalyzed cross‑coupling of the C–Cl bond is substantially more demanding than that of the C–Br or C–I bonds. Under typical Buchwald–Hartwig amination conditions—Pd₂(dba)₃ (2 mol %), XPhos (4 mol %), NaOtBu in toluene at 100 °C—the chloro substrate requires 24 h to reach 70 % conversion with a primary amine, whereas the bromo analogue reaches full conversion within 4 h at 80 °C with the same catalyst system. This reactivity gap renders the 2‑bromo derivative the preferred partner when constructing C–C or C–N bonds via palladium‑catalyzed routes, particularly in library synthesis where throughput is prioritized. However, the bromo ester’s cost premium (1.6–1.9× that of the chloro ester) and the need for cold‑chain transport (recommended storage below −20 °C) often drive early‑stage process chemists to engineer a nucleophilic displacement sequence that exploits the chloro derivative’s adequate reactivity at elevated temperature, reserving the bromo intermediate only for cases where milder conditions are necessary to protect sensitive functional groups elsewhere in the substrate. In practical amination sequences, however, non‑catalytic nucleophilic displacement with primary or secondary amines proceeds reliably with the chloro derivative. A representative protocol combines 1.0 eq of ethyl 2‑chloro‑1,3‑thiazole‑4‑carboxylate with 1.2 eq of amine and 1.5 eq of N,N‑diisopropylethylamine in anhydrous DMF at 80 °C for 12–18 h. After aqueous work‑up and trituration with cold ethanol, the isolated 2‑aminothiazole‑4‑carboxylate derivative is obtained in yields exceeding 85 % and with 98 % purity. The same transformation using the 2‑bromo ester can be completed in 6 h at 60 °C, but the moderate temperature advantage is frequently outweighed by the higher procurement cost and cold‑storage logistical constraints. Therefore, for large‑scale production of lower‑cost amine derivatives, the chloro intermediate often represents the economically favored choice, provided the extended reaction time does not introduce thermal decomposition of other functional groups.

    Key Operational Boundaries During Kilo‑Lab and Pilot‑Plant Scale‑Up

    Scaling amination and functionalization processes beyond the 100 g range with ethyl 2‑chloro‑1,3‑thiazole‑4‑carboxylate requires management of three interlocked operational boundaries: exotherm control during base addition, crystal morphology‑driven filtration rates, and trace water removal from polar aprotic solvents. During a 20‑kg production campaign of a 2‑piperazinyl‑thiazole API intermediate, reaction calorimetry (Mettler Toledo RC1e) determined that the adiabatic temperature rise for the DIPEA addition step reached 48 K. To maintain the reaction mass below 50 °C, the base was dosed over 90 min while the jacket temperature was held at –5 °C. Any deviation in dose rate leading to a bulk temperature exceeding 55 °C produced a sharp increase in the side‑product arising from thiazole ring‑opening, hitting 5 % within 20 min as confirmed by in‑line FTIR monitoring of the 1620 cm⁻¹ carbonyl band shift. Post‑reaction isolation of the crystalline product directly impacts plant throughput. The crude solid typically exhibits a needle‑like habit with aspect ratios above 10:1, a morphology that clogs sintered‑glass filters and extends filtration times beyond 4 h on a 0.6 m² Hastelloy nutsche. Introducing a 5 % (w/w) filter‑aid pre‑coat (diatomaceous earth, 20 µm median particle size) and maintaining a slurry temperature of 0–5 °C during transfer reduces filtration time to 90 min while keeping residual DMF below 0.1 %. Washing with chilled ethanol (0–5 °C) in two 15 L portions further removes soluble colored impurities. All polar aprotic solvents employed (DMF, NMP, DMSO) must be dried to ≤50 ppm water over 3 Å molecular sieves before use when ambient relative humidity exceeds 60 %. Failure to do so results in a drop in isolated yield of 8–12 % due to competitive hydrolysis of the ester as well as the chlorothiazole, verified by mass balance experiments on a 5‑kg pilot scale. These boundaries, taken together, have established a robust parameter set that has been transferred successfully across multiple toll‑manufacturing sites.